The FIRST and ONLY 96-well plate format Cytochrome P450 reductase (CPR) assay

MILPITAS, Calif. - May 15, 2015 - PRLog -- BioVision proudly announces the launch of a unique Cytochrome P450 reductase (CPR) activity assay kit which uses a synthetic colorimetric probe and a NADPH generating system. This assay has the advantage of a much longer linearity window (up to 20 mins) versus cytochrome c-based assays currently on the market allowing resolution of enzyme kinetics like never before.

Key Features:

- Easy-to-use

- Non-radioactive

- High throughput-adaptable

- Only 96-well plate format CPR activity kit on the market

Applications:

-Measurement of CPR activity in tissues, eukaryotic cells, purified microsomes (K249) or endoplasmic reticulum fractions

-Testing compounds that affect electron transfer by CPR in conjunction with various drug metabolizing enzymes like Cytochrome P450s

About BioVision's NEW Drug Metabolism Product Line :

BioVision, Inc. offers a variety of research products applicable to a broad spectrum of fields ranging from Diabetes, Stem-cell research, Neurobiology, Aging, Metabolic disorders, Cancer and more. We are quickly expanding a brand new line of Assay kits, ELISA kits and small molecule compounds specifically focusing on various targets applicable to drug design, drug metabolism or  drug-drug interactions. Check out http://www.biovision.com/drug-metabolism-and-disposition-...